320 related articles for article (PubMed ID: 30455434)
1. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist.
Ehrenmann J; Schöppe J; Klenk C; Rappas M; Kummer L; Doré AS; Plückthun A
Nat Struct Mol Biol; 2018 Dec; 25(12):1086-1092. PubMed ID: 30455434
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
Pioszak AA; Parker NR; Gardella TJ; Xu HE
J Biol Chem; 2009 Oct; 284(41):28382-28391. PubMed ID: 19674967
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of parathyroid hormone by its G protein-coupled receptor.
Pioszak AA; Xu HE
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5034-9. PubMed ID: 18375760
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
[TBL] [Abstract][Full Text] [Related]
5. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.
Pioszak AA; Harikumar KG; Parker NR; Miller LJ; Xu HE
J Biol Chem; 2010 Apr; 285(16):12435-44. PubMed ID: 20172855
[TBL] [Abstract][Full Text] [Related]
6. New views into class B GPCRs from the crystal structure of PTH1R.
Ehrenmann J; Schöppe J; Klenk C; Plückthun A
FEBS J; 2019 Dec; 286(24):4852-4860. PubMed ID: 31670461
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into peptide agonist engagement with the PTH receptor.
Cary BP; Gerrard EJ; Belousoff MJ; Fletcher MM; Jiang Y; Russell IC; Piper SJ; Wootten D; Sexton PM
Structure; 2023 Jun; 31(6):668-676.e5. PubMed ID: 37148874
[TBL] [Abstract][Full Text] [Related]
8. Structure and dynamics of the active human parathyroid hormone receptor-1.
Zhao LH; Ma S; Sutkeviciute I; Shen DD; Zhou XE; de Waal PW; Li CY; Kang Y; Clark LJ; Jean-Alphonse FG; White AD; Yang D; Dai A; Cai X; Chen J; Li C; Jiang Y; Watanabe T; Gardella TJ; Melcher K; Wang MW; Vilardaga JP; Xu HE; Zhang Y
Science; 2019 Apr; 364(6436):148-153. PubMed ID: 30975883
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1.
Zhao LH; Yuan QN; Dai AT; He XH; Chen CW; Zhang C; Xu YW; Zhou Y; Wang MW; Yang DH; Xu HE
Acta Pharmacol Sin; 2023 Jun; 44(6):1227-1237. PubMed ID: 36482086
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models.
Li M; Zhang X; Li S; Guo J
ACS Chem Neurosci; 2024 Feb; 15(4):844-853. PubMed ID: 38314550
[TBL] [Abstract][Full Text] [Related]
12. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
Bhattacharyya S; Pal S; Chattopadhyay N
Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
[TBL] [Abstract][Full Text] [Related]
13. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997
[TBL] [Abstract][Full Text] [Related]
14. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
15. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation.
Zhai X; Mao C; Shen Q; Zang S; Shen DD; Zhang H; Chen Z; Wang G; Zhang C; Zhang Y; Liu Z
Nat Commun; 2022 Oct; 13(1):6276. PubMed ID: 36271004
[TBL] [Abstract][Full Text] [Related]
17. Endogenous ligand recognition and structural transition of a human PTH receptor.
Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O
Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
19. Critical Extracellular Ca
Li M; Bao Y; Xu R; La H; Guo J
ACS Chem Neurosci; 2022 Jun; 13(11):1666-1674. PubMed ID: 35543321
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
Turner PR; Mefford S; Bambino T; Nissenson RA
J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
